As long as federal officials are pursuing the dual goals of exerting influence over the prescribing habits of medical professionals and reducing healthcare costs, they should acknowledge that therein lurks a potential conflict of interest.
But a lesson of the past century is that government can influence the behavior of big corporations, by requiring transparency about their performance and costs, and by enacting rules and limitations to protect the ordinary citizen.